Novartis India Limited (BOM:500672)
1,414.25
+52.65 (3.87%)
At close: May 26, 2026
Novartis India Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 6,677 | 520.7 | 449.8 | 194.2 | 1,584 |
Short-Term Investments | - | 5,850 | 5,400 | 5,350 | 3,579 |
Cash & Short-Term Investments | 6,677 | 6,371 | 5,850 | 5,544 | 5,163 |
Cash Growth | 4.81% | 8.91% | 5.51% | 7.38% | 3.80% |
Accounts Receivable | 370.5 | 401.4 | 414.7 | 361.6 | 445.6 |
Other Receivables | - | 89 | 94.7 | 130 | 116.4 |
Receivables | 370.5 | 490.4 | 509.4 | 491.6 | 566.6 |
Inventory | 533.2 | 411.1 | 448.6 | 547.2 | 570.7 |
Prepaid Expenses | - | 24.7 | 18.9 | 29.5 | 38.5 |
Other Current Assets | 101.8 | 161.3 | 165.9 | 160.8 | 748.6 |
Total Current Assets | 7,683 | 7,458 | 6,993 | 6,773 | 7,087 |
Property, Plant & Equipment | 28.8 | 45.4 | 69.4 | 192.5 | 236.5 |
Long-Term Deferred Tax Assets | 134.7 | 154.8 | 153.7 | 158 | 271.8 |
Other Long-Term Assets | 1,937 | 1,820 | 2,034 | 2,706 | 1,974 |
Total Assets | 9,783 | 9,478 | 9,249 | 9,829 | 9,576 |
Accounts Payable | 546.5 | 514.7 | 615.9 | 596.7 | 722 |
Accrued Expenses | - | 297.9 | 356.7 | 343.3 | 562.6 |
Short-Term Debt | - | - | 0.2 | - | - |
Current Portion of Leases | 16.4 | 18.5 | 18.8 | 41.2 | 57.4 |
Current Income Taxes Payable | 162.9 | 134.4 | 74.8 | 60.8 | 82.6 |
Other Current Liabilities | 723.9 | 455 | 505.6 | 552.9 | 739.6 |
Total Current Liabilities | 1,450 | 1,421 | 1,572 | 1,595 | 2,164 |
Long-Term Leases | 15.7 | 32.1 | 50.7 | 173.9 | 182.7 |
Pension & Post-Retirement Benefits | - | 144.5 | 145.7 | 188.4 | 255.6 |
Other Long-Term Liabilities | 139 | 31.4 | 32.7 | 115.6 | 56.2 |
Total Liabilities | 1,604 | 1,629 | 1,801 | 2,073 | 2,659 |
Common Stock | 123.4 | 123.4 | 123.4 | 123.4 | 123.4 |
Retained Earnings | - | 7,690 | 7,288 | 7,597 | 6,779 |
Comprehensive Income & Other | 8,055 | 36.4 | 36.4 | 36 | 14.2 |
Shareholders' Equity | 8,178 | 7,850 | 7,448 | 7,757 | 6,917 |
Total Liabilities & Equity | 9,783 | 9,478 | 9,249 | 9,829 | 9,576 |
Total Debt | 32.1 | 50.6 | 69.7 | 215.1 | 240.1 |
Net Cash (Debt) | 6,645 | 6,320 | 5,780 | 5,329 | 4,923 |
Net Cash Growth | 5.14% | 9.34% | 8.46% | 8.25% | 13.19% |
Net Cash Per Share | 269.13 | 255.97 | 234.10 | 215.83 | 199.38 |
Filing Date Shares Outstanding | 24.68 | 24.69 | 24.69 | 24.69 | 24.69 |
Total Common Shares Outstanding | 24.68 | 24.69 | 24.69 | 24.69 | 24.69 |
Working Capital | 6,233 | 6,038 | 5,421 | 5,178 | 4,923 |
Book Value Per Share | 331.34 | 317.92 | 301.66 | 314.15 | 280.14 |
Tangible Book Value | 8,178 | 7,850 | 7,448 | 7,757 | 6,917 |
Tangible Book Value Per Share | 331.34 | 317.92 | 301.66 | 314.15 | 280.14 |
Buildings | - | - | 0.5 | 0.5 | 0.9 |
Machinery | - | - | 45.1 | 47.7 | 80.5 |
Leasehold Improvements | - | 37.9 | 40.1 | 46.3 | 46.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.